Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
80%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_1

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

NCT06622434
completednot_applicable

A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity

NCT04515368
completednot_applicable

Experimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

NCT01236612
completednot_applicable

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

NCT01422954
completednot_applicable

Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

NCT01218893

Clinical Trials (5)

Showing 5 of 5 trials
NCT06622434Phase 1

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Recruiting
NCT04515368Not Applicable

A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity

Completed
NCT01236612Not Applicable

Experimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

Completed
NCT01422954Not Applicable

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

Completed
NCT01218893Not Applicable

Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5